IFNA1 and hepatocellular carcinoma: Despite these theoretical concerns about the reduced efficacy of recurrence suppression by IFN-free DAA regimens, the present study showed that the early recurrence rate of HCC was not different between patients who underwent IFN and those who underwent IFN-free DAA treatment.